Rochester, Minn.-based Mayo Clinic is collaborating with Profusa to investigate and commercialize clinical applications of the company’s oxygen monitoring technologies.
The partnership will explore new product development for intra-organ perfusion monitoring in cardiovascular, renal, multi-organ and orthopedic settings, according to a Feb. 13 news release from Profusa. It also aims to support the potential U.S. commercialization of Profusa’s tissue oxygen sensor for chronic limb-threatening ischemia.
Profusa’s platform is designed to enable continuous, real-time oxygen measurement within the body and has received more than $100 million in investment over more than a decade of development.
Mayo Clinic has a financial interest in the technology being developed through the collaboration. Any revenue the health system receives from the partnership will be reinvested to support its not-for-profit mission, which includes patient care, medical education and research, the release said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
